Literature DB >> 20949937

Addition of chitosan to silicate cross-linked PEO for tuning osteoblast cell adhesion and mineralization.

Akhilesh K Gaharwar1, Patrick J Schexnailder, Qu Jin, Chia-Jung Wu, Gudrun Schmidt.   

Abstract

The addition of chitosan to silicate (Laponite) cross-linked poly(ethylene oxide) (PEO) is used for tuning nanocomposite material properties and tailoring cellular adhesion and bioactivity. By combining the characteristics of chitosan (which promotes cell adhesion and growth, antimicrobial) with properties of PEO (prevents protein and cell adhesion) and those of Laponite (bioactive), the resulting material properties can be used to tune cellular adhesion and control biomineralization. Here, we present the hydration, dissolution, degradation, and mechanical properties of multiphase bio-nanocomposites and relate these to the cell growth of MC3T3-E1 mouse preosteoblast cells. We find that the structural integrity of these bio-nanocomposites is improved by the addition of chitosan, but the release of entrapped proteins is suppressed. Overall, this study shows how chitosan can be used to tune properties in Laponite cross-linked PEO for creating bioactive scaffolds to be considered for bone repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949937     DOI: 10.1021/am100609t

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  7 in total

1.  Antibiotic-loaded chitosan-Laponite films for local drug delivery by titanium implants: cell proliferation and drug release studies.

Authors:  Farideh Ordikhani; Mehdi Dehghani; Arash Simchi
Journal:  J Mater Sci Mater Med       Date:  2015-10-27       Impact factor: 3.896

2.  Evaluation of multifunctional polysaccharide hydrogels with varying stiffness for bone tissue engineering.

Authors:  Vaibhav Pandit; Jonathan M Zuidema; Kathryn N Venuto; James Macione; Guohao Dai; Ryan J Gilbert; Shiva P Kotha
Journal:  Tissue Eng Part A       Date:  2013-07-11       Impact factor: 3.845

Review 3.  Laponite-Based Nanomaterials for Drug Delivery.

Authors:  Gita Kiaee; Nikolaos Dimitrakakis; Shabnam Sharifzadeh; Han-Jun Kim; Reginald K Avery; Kamyar Mollozadeh Moghaddam; Reihaneh Haghniaz; Ezgi Pinar Yalcintas; Natan Roberto de Barros; Solmaz Karamikamkar; Alberto Libanori; Ali Khademhosseini; Parastoo Khoshakhlagh
Journal:  Adv Healthc Mater       Date:  2022-02-04       Impact factor: 9.933

4.  Novel 3D-printed methacrylated chitosan-laponite nanosilicate composite scaffolds enhance cell growth and biomineral formation in MC3T3 pre-osteoblasts.

Authors:  Tugba Cebe; Neelam Ahuja; Felipe Monte; Kamal Awad; Kimaya Vyavhare; Pranesh Aswath; Jian Huang; Marco Brotto; Venu Varanasi
Journal:  J Mater Res       Date:  2020-01-01       Impact factor: 2.909

Review 5.  Advances in Carbon Nanotubes-Hydrogel Hybrids in Nanomedicine for Therapeutics.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Vidya Sagar; Anujit Ghosal; Y K Gupta; Sharif Ahmad; Madhavan Nair
Journal:  Adv Healthc Mater       Date:  2018-02-01       Impact factor: 9.933

6.  Bio-multifunctional noncovalent porphyrin functionalized carbon-based nanocomposite.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Yousef Fatahi; Nafiseh Baheiraei; Moein Safarkhani; Abdullah Aldhaher; Rassoul Dinarvand
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

7.  LAPONITE® nanorods regulating degradability, acidic-alkaline microenvironment, apatite mineralization and MC3T3-E1 cells responses to poly(butylene succinate) based bio-nanocomposite scaffolds.

Authors:  Liangchen Tang; Wu Wei; Xuehong Wang; Jun Qian; Jianyou Li; Axiang He; Lili Yang; Xuesheng Jiang; Xiongfeng Li; Jie Wei
Journal:  RSC Adv       Date:  2018-03-19       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.